ATE71150T1 - Retrovirale polypeptide in zusammenhang mit menschlicher transformation. - Google Patents

Retrovirale polypeptide in zusammenhang mit menschlicher transformation.

Info

Publication number
ATE71150T1
ATE71150T1 AT85904763T AT85904763T ATE71150T1 AT E71150 T1 ATE71150 T1 AT E71150T1 AT 85904763 T AT85904763 T AT 85904763T AT 85904763 T AT85904763 T AT 85904763T AT E71150 T1 ATE71150 T1 AT E71150T1
Authority
AT
Austria
Prior art keywords
pct
transformation
polypeptides related
human
sec
Prior art date
Application number
AT85904763T
Other languages
English (en)
Inventor
Dennis J Slamon
Irvin S Y Chen
Martin J Cline
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE71150T1 publication Critical patent/ATE71150T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85904763T 1984-09-19 1985-09-19 Retrovirale polypeptide in zusammenhang mit menschlicher transformation. ATE71150T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65277584A 1984-09-19 1984-09-19
EP85904763A EP0196319B1 (de) 1984-09-19 1985-09-19 Retrovirale polypeptide in zusammenhang mit menschlicher transformation
PCT/US1985/001803 WO1986001834A1 (en) 1984-09-19 1985-09-19 Retroviral polypeptides associated with human cellular transformation

Publications (1)

Publication Number Publication Date
ATE71150T1 true ATE71150T1 (de) 1992-01-15

Family

ID=24618109

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85904763T ATE71150T1 (de) 1984-09-19 1985-09-19 Retrovirale polypeptide in zusammenhang mit menschlicher transformation.

Country Status (9)

Country Link
US (1) US5063150A (de)
EP (1) EP0196319B1 (de)
JP (2) JPS62500452A (de)
AT (1) ATE71150T1 (de)
AU (1) AU600224B2 (de)
DE (1) DE3585087D1 (de)
DK (1) DK228486A (de)
NO (1) NO861963L (de)
WO (1) WO1986001834A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US5176995A (en) * 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US5364933A (en) * 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5681696A (en) * 1987-01-09 1997-10-28 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
US5476765A (en) * 1987-01-09 1995-12-19 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
WO1990004020A1 (en) * 1988-10-06 1990-04-19 Dana Farber Cancer Institute H. saimiri-htlv-x region vector
JPH02186266A (ja) * 1988-10-14 1990-07-20 Eisai Co Ltd 経母乳感染の測定方法および試薬
EP0404935B1 (de) * 1989-01-13 1995-01-04 United Biomedical Inc. Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1
SE8900721D0 (sv) 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
US5292658A (en) * 1989-12-29 1994-03-08 University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center Cloning and expressions of Renilla luciferase
CA2094832A1 (en) * 1990-10-26 1992-04-27 Myron E. Essex Specific detection of antibodies to human t-cell leukemia viruses
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JP3506252B2 (ja) * 1992-02-24 2004-03-15 ジェネラブス・テクノロジーズ・インコーポレイテッド Htlv−i/htlv−iiの分析及び方法
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
JP5999703B2 (ja) * 2013-01-09 2016-09-28 国立大学法人 東京医科歯科大学 HLA−DR1拘束性Tax特異的CD4+T細胞エピトープ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides
US4341761A (en) * 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4438030A (en) * 1980-07-25 1984-03-20 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
NZ213823A (en) * 1984-10-26 1988-05-30 Us Health Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria

Also Published As

Publication number Publication date
EP0196319A1 (de) 1986-10-08
DK228486D0 (da) 1986-05-16
NO861963L (no) 1986-05-16
EP0196319B1 (de) 1992-01-02
DK228486A (da) 1986-05-16
DE3585087D1 (de) 1992-02-13
AU4866285A (en) 1986-04-08
US5063150A (en) 1991-11-05
WO1986001834A1 (en) 1986-03-27
JPS62500452A (ja) 1987-02-26
JPS6446651A (en) 1989-02-21
AU600224B2 (en) 1990-08-09
EP0196319A4 (de) 1989-08-29

Similar Documents

Publication Publication Date Title
ATE71150T1 (de) Retrovirale polypeptide in zusammenhang mit menschlicher transformation.
ES2065352T3 (es) Concentrado de proteinas no desnaturalizadas de suero lacteo.
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
FI902143A7 (fi) HIV-peptidit, keinotekoiset HIV-antigeenit ja immunomäärityspakkaukset
DE68925226D1 (de) Monoklonale Antikörper
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
ATE45285T1 (de) Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
YU46189B (sh) Monoklonska antitela i antigen za karcinome pluća čoveka koji ne pripadaju tipu "malih ćelija"
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
DK169986D0 (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
ES8802457A1 (es) Un procedimiento para la preparacion de polipeptidos inmunogenicos
ATE51709T1 (de) Antigen im zusammenhang mit der fruehzeitigen feststellung von schwangerschaft bei saeugern.
DK201590A (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
DK462887A (da) Forbedrede bestemmelser af myasthenia gravis og substrater og saet til anvendelse derved.
ATE40216T1 (de) Monoklonaler antikoerper.
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
DK513687A (da) Monoklonale antistoffer over for ifn-omega, fremgangsmaade til deres fremstilling og deres anvendelse til rensning samt paavisning af ifn-omega
DK528279A (da) Fremgangsmaade til isolering af hepatitis b e antigen eller antistof
DE69026812D1 (de) Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern
EP0253873A4 (de) Lymphocyten-aktivierende polypeptide.
ATE245661T1 (de) Natürliche menschliche igm antikörper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee